Spoken Alpha
TLRY
Tilray Brands, Inc.
Overview
Tilray Brands, Inc is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $397.5M market cap.
Most recent reported earnings: Q1 FY2027 (Oct 7, 2026).
24 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2027Earnings2026-10-0811 Q&A exchanges
- Q4 FY2026Earnings2026-07-2812 Q&A exchanges
- Q2 FY2026Earnings2026-01-089 Q&A exchanges
- Q1 FY2026Earnings2025-10-099 Q&A exchanges
- Q4 FY2025Earnings2025-07-2814 Q&A exchanges
- Q3 FY2025Earnings2025-04-0820 Q&A exchanges
- Q2 FY2025Earnings2025-01-0923 Q&A exchanges
- Q1 FY2025Earnings2024-10-1024 Q&A exchanges
- Q4 FY2024Earnings2024-07-2920 Q&A exchanges
- Q3 FY2024Earnings2024-04-0918 Q&A exchanges
- Q2 FY2024Earnings2024-01-0920 Q&A exchanges
- Q1 FY2024Earnings2023-10-0420 Q&A exchanges
- Q4 FY2023Earnings2023-07-2611 Q&A exchanges
- Q3 FY2023Earnings2023-04-1017 Q&A exchanges
- Q2 FY2023Earnings2023-01-0917 Q&A exchanges
- Q1 FY2023Earnings2022-10-0719 Q&A exchanges
- Q4 FY2022Earnings2022-07-2831 Q&A exchanges
- Q3 FY2022Earnings2022-04-0617 Q&A exchanges
- Q2 FY2022Earnings2022-01-1013 Q&A exchanges
- Q1 FY2022Earnings2021-10-0725 Q&A exchanges
- Q4 FY2021Earnings2021-07-2811 Q&A exchanges
- Q3 FY2021Earnings2021-04-1216 Q&A exchanges
- Q2 FY2021Earnings2021-01-1418 Q&A exchanges
- Q1 FY2021Earnings2020-10-1521 Q&A exchanges
History
Earnings history
- Q1 FY20272026-10-07EPS— vs $-0.18—Rev— vs ——EODHD
- Q4 FY20262026-07-27EPS$-0.43 vs $-0.02-100.0%Rev$281.7M vs ——EODHD
- Q3 FY20262026-03-31EPS$0.02 vs $0.07-71.4%Rev$282.2M vs ——EODHD
- Q2 FY20262026-01-07EPS$-0.02 vs $-0.02-8.1%Rev$303.9M vs ——EODHD
- Q1 FY20262025-10-08EPS$-0.00 vs $-0.04+99.3%Rev$287.8M vs ——EODHD
- Q4 FY20252025-07-27EPS$0.02 vs $-0.02+100.0%Rev$308.1M vs ——EODHD
- Q3 FY20252025-04-07EPS$-0.87 vs $-0.33-100.0%Rev$268.3M vs ——EODHD
- Q2 FY20252025-01-09EPS$-0.03 vs $-0.13+76.9%Rev$295.1M vs ——EODHD
- Q1 FY20252024-10-09EPS$-0.10 vs $-0.30+66.7%Rev$269.8M vs ——EODHD
- Q4 FY20242024-07-28EPS$-0.04 vs $-0.02-100.0%Rev$313.2M vs ——EODHD
- Q3 FY20242024-04-08EPS$-0.12 vs $-0.47+74.5%Rev$255.6M vs ——EODHD
- Q2 FY20242024-01-08EPS$-0.60 vs $-0.47-27.7%Rev$262.4M vs ——EODHD
- Q1 FY20242023-10-03EPS$-0.91 vs $-0.57-59.7%Rev$239.7M vs ——EODHD
- Q4 FY20232023-07-25EPS$-0.15 vs $-0.05-100.0%Rev$184.2M vs ——EODHD
- Q3 FY20232023-04-09EPS$-0.40 vs $-0.58+31.0%Rev$198.1M vs ——EODHD
- Q2 FY20232023-01-08EPS$-0.60 vs $-0.54-11.1%Rev$194.4M vs ——EODHD
- Q1 FY20232022-10-06EPS$-0.80 vs $-0.70-14.3%Rev$201.2M vs ——EODHD
- Q4 FY20222022-07-27EPS$-0.90 vs $-0.08-100.0%Rev$193.3M vs ——EODHD
- Q3 FY20222022-04-05EPS$0.74 vs $-0.79+100.0%Rev$193.1M vs ——EODHD
- Q2 FY20222022-01-09EPS$0.03 vs $-0.77+100.0%Rev$198.6M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 2026-10-07 | — | $-0.18 | — | — | — | — | EODHD |
| Q4 FY2026 | 2026-07-27 | $-0.43 | $-0.02 | -100.0% | $281.7M | — | — | EODHD |
| Q3 FY2026 | 2026-03-31 | $0.02 | $0.07 | -71.4% | $282.2M | — | — | EODHD |
| Q2 FY2026 | 2026-01-07 | $-0.02 | $-0.02 | -8.1% | $303.9M | — | — | EODHD |
| Q1 FY2026 | 2025-10-08 | $-0.00 | $-0.04 | +99.3% | $287.8M | — | — | EODHD |
| Q4 FY2025 | 2025-07-27 | $0.02 | $-0.02 | +100.0% | $308.1M | — | — | EODHD |
| Q3 FY2025 | 2025-04-07 | $-0.87 | $-0.33 | -100.0% | $268.3M | — | — | EODHD |
| Q2 FY2025 | 2025-01-09 | $-0.03 | $-0.13 | +76.9% | $295.1M | — | — | EODHD |
| Q1 FY2025 | 2024-10-09 | $-0.10 | $-0.30 | +66.7% | $269.8M | — | — | EODHD |
| Q4 FY2024 | 2024-07-28 | $-0.04 | $-0.02 | -100.0% | $313.2M | — | — | EODHD |
| Q3 FY2024 | 2024-04-08 | $-0.12 | $-0.47 | +74.5% | $255.6M | — | — | EODHD |
| Q2 FY2024 | 2024-01-08 | $-0.60 | $-0.47 | -27.7% | $262.4M | — | — | EODHD |
| Q1 FY2024 | 2023-10-03 | $-0.91 | $-0.57 | -59.7% | $239.7M | — | — | EODHD |
| Q4 FY2023 | 2023-07-25 | $-0.15 | $-0.05 | -100.0% | $184.2M | — | — | EODHD |
| Q3 FY2023 | 2023-04-09 | $-0.40 | $-0.58 | +31.0% | $198.1M | — | — | EODHD |
| Q2 FY2023 | 2023-01-08 | $-0.60 | $-0.54 | -11.1% | $194.4M | — | — | EODHD |
| Q1 FY2023 | 2022-10-06 | $-0.80 | $-0.70 | -14.3% | $201.2M | — | — | EODHD |
| Q4 FY2022 | 2022-07-27 | $-0.90 | $-0.08 | -100.0% | $193.3M | — | — | EODHD |
| Q3 FY2022 | 2022-04-05 | $0.74 | $-0.79 | +100.0% | $193.1M | — | — | EODHD |
| Q2 FY2022 | 2022-01-09 | $0.03 | $-0.77 | +100.0% | $198.6M | — | — | EODHD |
Source: EODHD. TLRY reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Irwin D SimonCEO5 yr 7 mo23 callsCurrent
- Carl A MertonCFO5 yr 7 mo24 callsCurrent
- Denise M FaltischekChief Strategy Officer5 yr 7 mo13 callsCurrent
- Mitchell GendelGlobal General Counsel5 yr 4 mono recorded callsCurrent
- Brendan KennedyCEO2 yr 9 mono recorded callsFormer
- Michael C KruteckCFO1 yr 1 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TLRY.
$ curl https://api.spokenalpha.com/v1/companies/TLRYFAQ
Frequently asked about TLRY
Where can I find Tilray Brands, Inc.'s (TLRY) earnings call transcripts?
Spoken Alpha indexes TLRY's earnings call transcripts at https://spokenalpha.com/companies/TLRY. Each call links to attributed speakers and parsed analyst Q&A. Tilray Brands, Inc.'s own investor relations page is at https://www.tilray.com/investors.
When was Tilray Brands, Inc.'s most recent earnings call?
Tilray Brands, Inc. (TLRY) held its most recent earnings call on 2026-10-08, covering fiscal Q1 2027.
What sector is TLRY in?
Tilray Brands, Inc. (TLRY) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).